Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Open, Non-randomized Phase I/II Study of Therapeutic Angiogenesis in Diabetic Patients With Critic Ischemia of Lower Limbs While Administering Positive CD133 Mobilized With G-CSF

NCT00765050 is registered in ClinicalTrials.gov with PETHEMA Foundation as lead sponsor.

NCT NCT00765050
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00765050 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Open, Non-randomized Phase I/II Study of Therapeutic Angiogenesis in Diabetic Patients With Critic Ischemia of Lower Limbs While Administering Positive CD133 Mobilized With G-CSF
Lead sponsor
PETHEMA Foundation
Phase
Phase 1/2
Overall status
Terminated
Start date
January 31, 2009
Completion date
October 31, 2012
Enrollment
13 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic patients with critic ischemia in lower limbs who are administered with cd133+ cells mobilized by g-csf